scholarly article | Q13442814 |
P50 | author | Loic Le Marchand | Q28360612 |
Veronica Wendy Setiawan | Q28805341 | ||
Christopher A. Haiman | Q73606228 | ||
Brian E. Henderson | Q73660621 | ||
Giske Ursin | Q46387795 | ||
Leslie Bernstein | Q60607806 | ||
David Van Den Berg | Q60686183 | ||
Pamela L Horn-Ross | Q60716556 | ||
Pedram Razavi | Q63869181 | ||
P2093 | author name string | Eunjung Lee | |
Chris Hsu | |||
P2860 | cites work | A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk | Q24535819 |
The structure of haplotype blocks in the human genome | Q27860500 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population | Q29614401 | ||
Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study | Q30815307 | ||
Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center. | Q31149715 | ||
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform | Q74281193 | ||
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone | Q77636062 | ||
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development | Q79753736 | ||
Long-term postmenopausal hormone therapy and endometrial cancer | Q33650188 | ||
Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones | Q34491637 | ||
No association between progesterone receptor gene +331G/A polymorphism and endometrial cancer | Q34546683 | ||
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review | Q35032177 | ||
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics | Q35786223 | ||
Reproductive tissue selective actions of progesterone receptors. | Q35848877 | ||
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases | Q35857243 | ||
A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. | Q36080535 | ||
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk | Q36465880 | ||
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis | Q36614790 | ||
Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review | Q36655780 | ||
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium | Q37157438 | ||
Endometrioid carcinoma of the ovary: retrospective review of 145 cases | Q38009676 | ||
Estrogen-progestin replacement therapy and endometrial cancer | Q38504098 | ||
Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer | Q39553740 | ||
High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). | Q40631500 | ||
No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. | Q43007578 | ||
Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients | Q43773489 | ||
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina | Q44082612 | ||
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort | Q44307819 | ||
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. | Q45173699 | ||
Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis | Q45211865 | ||
Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma | Q45279423 | ||
Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer | Q46667600 | ||
Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer | Q46855999 | ||
Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion | Q48072384 | ||
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. | Q51799857 | ||
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. | Q52930435 | ||
Endometrial cancer | Q63199203 | ||
Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria | Q71100414 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | genetic variation | Q349856 |
endometrial cancer | Q944777 | ||
P304 | page(s) | 1392-1399 | |
P577 | publication date | 2010-06-13 | |
P1433 | published in | Carcinogenesis | Q326022 |
P1476 | title | Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach | |
P478 | volume | 31 |
Q37691657 | An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors |
Q34562166 | Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis |
Q37260827 | Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women |
Q44636781 | Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis. |
Q34096825 | Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia |
Q39373892 | Gene x environment interactions impact endometrial function and the menstrual cycle: PROGINS, life history, anthropometry, and physical activity |
Q28260010 | Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats |
Q91583952 | Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection |
Q35018327 | Progesterone receptor gene variants and risk of endometrial cancer |
Q55297932 | Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. |
Q33809605 | The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers |
Q47246925 | Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers |
Search more.